Antibody testing will enhance the power and accuracy of COVID-19-prevention trials

Nat Med. 2020 Jun;26(6):818-819. doi: 10.1038/s41591-020-0887-3.

Marc Lipsitch^{1

2}, Rebecca Kahn³, Michael J Mina^{3

4}

¹ Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. mlipsitc@hsph.harvard.edu.
² Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Mam, USA. mlipsitc@hsph.harvard.edu.
³ Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
⁴ Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Mam, USA.

No abstract available

MeSH terms